Research on psilocybin and psychedelic mushroom extract has shown potential therapeutic effects, with some studies indicating that a single dose may have long-term benefits for conditions such as obsessive-compulsive disorder. However, the outcomes of these studies appear to be mixed, with some findings suggesting benefits for conditions like OCD and depression, while others raise concerns about potential negative effects, such as exacerbating postpartum depression-like symptoms in mice. The exact implications of this research are unclear, with different studies reporting varying results.